TrialThoracic cancer2025

Dysbiosis in the Gut Microbiome of Pembrolizumab-Treated Non-Small Lung Cancer Patients Compared to Healthy Controls Characterized Through Opportunistic Sampling.

Haris Charalambous et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.